Cargando…
Thyroid Cancer and Fibroblasts
SIMPLE SUMMARY: Thyroid cancer is the most common solid tumor of the endocrine glands. The cancer cell contribution to thyroid cancer development and progression has been studied extensively, whereas the involvement of the tumor microenvironment, particularly of cancer-associated fibroblasts (CAFs),...
Autores principales: | Avagliano, Angelica, Fiume, Giuseppe, Bellevicine, Claudio, Troncone, Giancarlo, Venuta, Alessandro, Acampora, Vittoria, De Lella, Sabrina, Ruocco, Maria Rosaria, Masone, Stefania, Velotti, Nunzio, Carotenuto, Pietro, Mallardo, Massimo, Caiazza, Carmen, Montagnani, Stefania, Arcucci, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455043/ https://www.ncbi.nlm.nih.gov/pubmed/36077709 http://dx.doi.org/10.3390/cancers14174172 |
Ejemplares similares
-
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation
por: Romano, Veronica, et al.
Publicado: (2022) -
Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape
por: Romano, Veronica, et al.
Publicado: (2021) -
Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination
por: Avagliano, Angelica, et al.
Publicado: (2020) -
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts
por: Avagliano, Angelica, et al.
Publicado: (2019) -
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation
por: Granato, Giuseppina, et al.
Publicado: (2017)